DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 207 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $415,875 | +22.9% | 42,393 | +33.3% | 0.01% | -18.8% |
| Q4 2022 | $338,448 | -13.2% | 31,809 | -14.8% | 0.02% | +23.1% |
| Q3 2022 | $390,000 | -23.5% | 37,322 | -6.5% | 0.01% | -13.3% |
| Q2 2022 | $510,000 | +22.3% | 39,906 | +5.3% | 0.02% | +87.5% |
| Q1 2022 | $417,000 | -19.2% | 37,893 | +4.5% | 0.01% | -20.0% |
| Q4 2021 | $516,000 | -36.6% | 36,260 | -13.4% | 0.01% | -33.3% |
| Q3 2021 | $814,000 | +143.7% | 41,879 | +23.9% | 0.02% | +200.0% |
| Q2 2021 | $334,000 | +3.4% | 33,799 | -2.6% | 0.01% | -16.7% |
| Q1 2021 | $323,000 | +23.8% | 34,697 | -34.9% | 0.01% | 0.0% |
| Q4 2020 | $261,000 | -3.3% | 53,266 | -13.2% | 0.01% | -33.3% |
| Q3 2020 | $270,000 | +5.5% | 61,372 | +103.6% | 0.01% | 0.0% |
| Q2 2020 | $256,000 | – | 30,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |